Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells

被引:0
|
作者
Motwani, M [1 ]
Li, XK [1 ]
Schwartz, GK [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Gastrointestinal Oncol Res Lab, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Defects in cell cycle checkpoints can lead to chromosome abnormality, aneuploidy, and genomic instability, all of which can contribute to tumorigenesis. Recent studies and data presented in this study indicate that cells with compromised G(1) checkpoint endoreduplicate and become polyploid in response to microtubule inhibitors, Previous studies have shown that polyploid cells are unstable and lose chromosomes randomly to give aneuploidy, In this study, we show that endoreduplication and polyploidation can be prevented by inhibiting the cyclin-dependent kinases (Cdks) by flavopiridol, a synthetic flavone presently undergoing phase II clinical trials. In our initial studies, we treated MCF-7 cells with paclitaxel, which results in the arrest of cells in G(1) with 4n DNA content (pseudo G(1)), This was coincident with increased p53 and p21 protein expression and decreased cyclin E/Cdk2 kinase activity. In contrast, G(1) checkpoint-compromised MDA-MB-468 (p53-/- and pRb-/-) and p21-/- HCT116 do not arrest in the pseudo G(1) state after exposure to microtubule inhibitors and enter in the S phase with 4n DNA content. More than 60% of MDA-MB-468 cells accumulate with >4n DNA content after 72 h of nocodazole treatment. The MPM-2 labeling showed that 8n cells also undergo mitosis, These cells display deregulated and persistent activation of cyclin E/Cdk2 and cyclin B1/cdc2 kinase activity. Administration of flavopiridol after mitotic block results in the arrest of cells in the pseudo G(1) state and the dramatic decrease in cells containing >4n DNA content in MDA-MB-468 cells. The cyclin E/Cdk2 and cyclin B1/cdc2 kinase activities remained low after exit from mitosis, Furthermore, pRb was hypophosphorylated after the addition of flavopiridol in p21-deficient HCT116 cells, indicating the arrest of cells at the pseudo G(1) state, Based on these studies, we propose that flavopiridol preserves the genomic stability by preventing endoreduplication and polyploidy and thus has the potential to be used as a chemopreventive agent to prevent the occurrence of neoplasia.
引用
收藏
页码:924 / 932
页数:9
相关论文
共 50 条
  • [21] CYCLIN-DEPENDENT KINASE INHIBITOR FLAVOPIRIDOL ENHANCES CYTOTOXIC ACTION OF DNA-DAMAGING AGENTS ON HUMAN GLIOMA CELLS
    Hirose, Yuichi
    Ohba, Shigeo
    Kawase, Takeshi
    Sano, Hirotoshi
    NEURO-ONCOLOGY, 2009, 11 (02) : 222 - 222
  • [22] Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
    Saisomboon, Saowaluk
    Kariya, Ryusho
    Vaeteewoottacharn, Kulthida
    Wongkham, Sopit
    Sawanyawisuth, Kanlayanee
    Okada, Seiji
    HELIYON, 2019, 5 (05)
  • [23] Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
    Hassan, Md Sazzad
    Cwidak, Nicholas
    Johnson, Chloe
    Daester, Silvio
    Eppenberger-Castori, Serenella
    Awasthi, Niranjan
    Li, Jun
    Schwarz, Margaret A.
    von Holzen, Urs
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Flavopiridol as cyclin dependent kinase (CDK) inhibitor: a review
    Deep, Aakash
    Marwaha, Rakesh Kumar
    Marwaha, Minakshi Gupta
    Jyoti
    Nandal, Rimmy
    Sharma, Arun Kumar
    NEW JOURNAL OF CHEMISTRY, 2018, 42 (23) : 18500 - 18507
  • [25] Flavopiridol, a cyclin-dependent kinase inhibitor, represses HIV-1 transcription in macrophages
    Caldwell, RL
    Shepherd, VL
    FASEB JOURNAL, 2003, 17 (05): : A1039 - A1039
  • [26] The specific overexpression of a cyclin-dependent kinase inhibitor in tomato fruit mesocarp cells uncouples endoreduplication and cell growth
    Nafati, Mehdi
    Cheniclet, Catherine
    Hernould, Michel
    Do, Phuc T.
    Fernie, Alisdair R.
    Chevalier, Christian
    Gevaudant, Frederic
    PLANT JOURNAL, 2011, 65 (04): : 543 - 556
  • [27] Sensitization of cervical cancer cells to radiation by the cyclin-dependent kinase inhibitor dinaciclib
    Zhang, Haichen
    Chu, Tong
    Zheng, Jin
    Teng, Yun
    Ma, Ruilan
    Zou, Lijuan
    Zhao, Haidong
    MEDICAL ONCOLOGY, 2022, 40 (02)
  • [28] Sensitization of cervical cancer cells to radiation by the cyclin-dependent kinase inhibitor dinaciclib
    Haichen Zhang
    Tong Chu
    Jin Zheng
    Yun Teng
    Ruilan Ma
    Lijuan Zou
    Haidong Zhao
    Medical Oncology, 40
  • [29] Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer
    Tan, AR
    Yang, XW
    Berman, A
    Zhai, SP
    Sparreboom, A
    Parr, AL
    Chow, C
    Brahim, JS
    Steinberg, SM
    Figg, WD
    Swain, SM
    CLINICAL CANCER RESEARCH, 2004, 10 (15) : 5038 - 5047
  • [30] Pharmacodynamic assessment of the cyclin-dependent kinase inhibitor flavopiridol: Modulation of cdk targets in clinical samples
    Di Vizio, D
    O'Connell, FP
    Bhattacharya, N
    Shapiro, GI
    Loda, M
    MODERN PATHOLOGY, 2005, 18 : 297A - 297A